Preclinical News and Research

RSS
Rexahn Pharmaceuticals signs license agreement with UMB for novel drug delivery platform

Rexahn Pharmaceuticals signs license agreement with UMB for novel drug delivery platform

Sequella licenses Pfizer's exclusive worldwide rights to develop, commercialize sutezolid

Sequella licenses Pfizer's exclusive worldwide rights to develop, commercialize sutezolid

Study identifies new therapeutic targets for Huntington's disease

Study identifies new therapeutic targets for Huntington's disease

Alize Pharma initiates AZP-531 Phase I clinical trial for treatment of type 2 diabetes

Alize Pharma initiates AZP-531 Phase I clinical trial for treatment of type 2 diabetes

Ipsen closes acquisition of UK-based Syntaxin

Ipsen closes acquisition of UK-based Syntaxin

C2N Diagnostics, CIL sign collaborative research and global supplier agreement

C2N Diagnostics, CIL sign collaborative research and global supplier agreement

International team explores genetic diversity of Plasmodium vivax in the Americas

International team explores genetic diversity of Plasmodium vivax in the Americas

Antibodies boost immune system to fight childhood cancer, shows study

Antibodies boost immune system to fight childhood cancer, shows study

Alnylam releases positive top-line data from ALN-TTRsc Phase I trial for TTR-mediated amyloidosis

Alnylam releases positive top-line data from ALN-TTRsc Phase I trial for TTR-mediated amyloidosis

Protein that triggers blood clotting plays critical role in growth of pancreatic and breast cancer

Protein that triggers blood clotting plays critical role in growth of pancreatic and breast cancer

Heart transplant could get a second chance to save life

Heart transplant could get a second chance to save life

Immunocore, GSK partner for cancer targeting ImmTACs

Immunocore, GSK partner for cancer targeting ImmTACs

Research: Boosting levels of gut hormones may be effective weapon in fight against obesity

Research: Boosting levels of gut hormones may be effective weapon in fight against obesity

Boehringer Ingelheim signs multi-year renewal agreement to NextBio Research Platform

Boehringer Ingelheim signs multi-year renewal agreement to NextBio Research Platform

Viewpoints: Health care's hidden consensus; Examining the fee-for-service payment system; Alternative medicine's allure

Viewpoints: Health care's hidden consensus; Examining the fee-for-service payment system; Alternative medicine's allure

Cancer immunotherapies promise to be a new tool in fight against cancer

Cancer immunotherapies promise to be a new tool in fight against cancer

Mouse study identifies new treatment options for bowel cancer

Mouse study identifies new treatment options for bowel cancer

Soy peptide injection dramatically reduces colon cancer metastasis in mice

Soy peptide injection dramatically reduces colon cancer metastasis in mice

Anti-cancer compounds offer hope for treating breast cancer

Anti-cancer compounds offer hope for treating breast cancer

VBL Therapeutics publishes VB-201 pre-clinical data in journal of Atherosclerosis

VBL Therapeutics publishes VB-201 pre-clinical data in journal of Atherosclerosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.